Published Erratum Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025 Jun 12:118232. doi: 10.1016/j.biopha.2025.118232 Q17.52025
Corrigendum to "Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence" [Biomed. Pharmacother. 188 (2025) 118199]
关于“氯胺酮治疗能否克服阿尔茨海默病和老年人难治性抑郁症？前临床和临床证据”一文的勘误[生物医学与药物治疗学第188卷（2025年）118199号论文] 翻译改进
Mario Altamura 1, Ivana Leccisotti 2, Maria Claudia Moretti 2, Antonello Bellomo 2, Francesco Panza 3, Tommaso Cassano 4, Madia Lozupone 5
作者单位 +展开
作者单位
DOI: 10.1016/j.biopha.2025.118232 PMID: 40514286
摘要 中英对照阅读
相关内容
-
Maintenance Ketamine Therapy for Treatment-Resistant Depression
难治性抑郁的氯胺酮维持治疗
Shaina Archer
Journal of clinical psychopharmacology. 2018 Aug;38(4):380-384.
-
Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?
治疗抵抗型抑郁的未来治疗方法：氯胺酮的作用？
Spencer Kwak
The Journal of the Oklahoma State Medical Association. 2015 Mar;108(3):88-9.
-
Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report
氯胺酮联合经颅磁刺激治疗难治性抑郁的病例报告
Steven Richard Devore Best
The International journal of neuroscience. 2015 Mar;125(3):232-4.
-
Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
关于Ketamine联合拉莫三嗪治疗难治性抑郁的初步研究报告的更正：Pharmaceuticals 2023, 16, 1164
Boney Joseph et al.
Pharmaceuticals (Basel, Switzerland). 2023 Nov 7;16(11):1571.
-
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
整合式氯胺酮治疗可增强疗效的多个维度：利用难治性抑郁症改善治疗结果
Sherry-Anne Muscat et al.
Frontiers in psychiatry. 2021 Nov 24:12:710338.
-
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
治疗难治性抑郁症的氯胺酮疗法中的铜浓度
Jakub Słupski et al.
Brain sciences. 2020 Dec 11;10(12):971.
-
Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report
难治性抑郁发作克治疗多发性硬化病的病例报告
Michael M Messer
Innovations in clinical neuroscience. 2017 Feb 1;14(1-2):56-59.
-
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
单用氯胺酮与联合使用氯胺酮治疗难治性抑郁成人患者的效果：来自加拿大快速治疗卓越中心的研究结果
Joshua D Di Vincenzo et al.
Journal of psychiatric research. 2021 Nov:143:209-214.
期刊名：Biomedicine & pharmacotherapy
缩写：BIOMED PHARMACOTHER
ISSN：0753-3322
e-ISSN：1950-6007
IF/分区：7.5/Q1
引文链接
复制
已复制！
推荐内容
Corrigendum to "Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence" [Biomed. Pharmacother. 188 (2025) 118199]